Ewing's Tumor Metastatic Active Not Recruiting Phase 3 Trials for Temozolomide (DB00853)

Also known as: Ewing's tumour metastatic / Ewing's sarcoma metastatic

IndicationStatusPhase
DBCOND0083526 (Ewing's Tumor Metastatic)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03495921Vigil + Irinotecan and Temozolomide in Ewing's SarcomaTreatment